AdaptHealth Corp. (NASDAQ:AHCO) Shares Sold by Sapience Investments LLC

Sapience Investments LLC reduced its holdings in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 14.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 214,420 shares of the company's stock after selling 35,280 shares during the period. Sapience Investments LLC owned about 0.16% of AdaptHealth worth $2,041,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in AHCO. Pacer Advisors Inc. acquired a new stake in shares of AdaptHealth during the 4th quarter worth approximately $76,271,000. Principal Financial Group Inc. boosted its holdings in AdaptHealth by 204.0% during the fourth quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company's stock worth $15,735,000 after buying an additional 1,109,021 shares in the last quarter. Segall Bryant & Hamill LLC grew its position in AdaptHealth by 29.8% during the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock valued at $45,734,000 after buying an additional 1,102,173 shares during the period. Dimensional Fund Advisors LP grew its position in AdaptHealth by 17.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company's stock valued at $32,174,000 after buying an additional 505,180 shares during the period. Finally, Bridgeway Capital Management LLC increased its holdings in AdaptHealth by 27.2% in the fourth quarter. Bridgeway Capital Management LLC now owns 1,324,043 shares of the company's stock valued at $12,605,000 after buying an additional 283,143 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company's stock.

AdaptHealth Stock Down 1.3%

Shares of NASDAQ AHCO traded down $0.12 during midday trading on Thursday, hitting $8.95. The company's stock had a trading volume of 287,843 shares, compared to its average volume of 1,278,274. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The firm has a market capitalization of $1.21 billion, a price-to-earnings ratio of -5.42, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64. The business's fifty day simple moving average is $9.12 and its two-hundred day simple moving average is $9.65. AdaptHealth Corp. has a 1 year low of $7.11 and a 1 year high of $11.90.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on AHCO. UBS Group cut their price objective on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, February 13th. Truist Financial cut their price target on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Royal Bank of Canada reduced their price objective on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a research report on Thursday, May 8th. Robert W. Baird increased their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Finally, Canaccord Genuity Group lifted their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth presently has a consensus rating of "Buy" and an average price target of $13.40.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.